INDEX NAME NOT YET ASSIGNED

INDEX NAME NOT YET ASSIGNED Suppliers list
Company Name: DC Chemicals  
Tel: 021-58447131 13564518121
Email: sales@dcchemicals.com
Products Intro: Product Name:IM-250
CAS:2305750-23-4
Purity:98% HPLC Package:100mg,250mg,1g
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310
Email: marketing@tsbiochem.com
Products Intro: Product Name:IM-250
CAS:2305750-23-4
Purity:99.59% Package:1mg/RMB 1560;5mg/RMB 5230;10mg/RMB 7190
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Tel: 0513-66337626 18051384581
Email: sales@chemhifuture.com
Products Intro: Product Name:IM-250
CAS:2305750-23-4
Purity:98%+ HPLC Package:10mg,500mg,1g,2g,5g,10mg,more
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Products Intro: Product Name:IM-250
CAS:2305750-23-4
Purity:99% Package:1mg;5mg;10mg
Company Name: Sangon Biotech (Shanghai) Co.,Ltd.  
Tel: 400-821-026
Email: Sales@sangon.com
Products Intro: Product Name:IM-250
CAS:2305750-23-4
INDEX NAME NOT YET ASSIGNED Basic information
Product Name:INDEX NAME NOT YET ASSIGNED
Synonyms:IM-250;[1,1′-Biphenyl]-4-acetamide, 2′,5′-difluoro-N-methyl-N-[4-methyl-5-[[S(S)]-S-methylsulfonimidoyl]-2-thiazolyl]-
CAS:2305750-23-4
MF:C20H19F2N3O2S2
MW:435.51
EINECS:
Product Categories:
Mol File:2305750-23-4.mol
INDEX NAME NOT YET ASSIGNED Structure
INDEX NAME NOT YET ASSIGNED Chemical Properties
Boiling point 573.0±60.0 °C(Predicted)
density 1.36±0.1 g/cm3(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
INDEX NAME NOT YET ASSIGNED Usage And Synthesis
UsesIM-250 is an orally active helicase-primase inhibitor. IM-250 is effective against HSV infection. IM-250 inhibits HSV-1 infection in Vero cells (IC50: ~20 nM)[1][2].
References[1] Bernstein DI, et al. Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV. Antiviral Res. 2023 Nov;219:105733. DOI:10.1016/j.antiviral.2023.105733
[2] Uhlig N, et al. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model. Antiviral Res. 2021 Nov;195:105190. DOI:10.1016/j.antiviral.2021.105190
INDEX NAME NOT YET ASSIGNED Preparation Products And Raw materials
Tag:INDEX NAME NOT YET ASSIGNED(2305750-23-4) Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.